Citations 1
Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
O’Neill, Anne, Dang, Chau T. , Northfelt, Donald W. , Gradishar, William J. , Goldstein, Lori J. , Brufsky, Adam , Bloom, Stuart H. , Fox, Kevin R., Hendricks, Carolyn B., Balcueva, Ernie, Brufsky, Adam M , Miller, Kathy D. , Mayer, Ingrid A. , Sparano, Joseph A. , Tevaarwerk, Amyé , Sledge, George W.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 500-500
